DrugLib.com — Drug Information Portal

Rx drug information, pharmaceutical research, clinical trials, news, and more

Maxipime (Cefepime) - Renal Impairment - Suspected Cause - Side Effect Reports

 
 



Index of reports > Cases with Renal Impairment (4)

Below is the selection of side effect reports (a.k.a. adverse event reports) related to Maxipime (Cefepime) where reactions include renal impairment. The selected reports were submitted to the FDA during the sample period of about a year.

Possible Maxipime side effects in male

Reported by a physician from Japan on 2012-08-13

Patient: male, weighing 54.0 kg (118.8 pounds)

Reactions: Pyrexia, Multiple Myeloma, Hypokalaemia, Haematocrit Decreased, Malaise, RED Blood Cell Count Decreased, DRY Mouth, Hypocalcaemia, Blood Creatinine Increased, Renal Failure Acute, Decreased Appetite, Biopsy Kidney Abnormal, Urine Output Decreased, Urinary Casts Present, Haemoglobin Decreased, Renal Impairment, Neoplasm Malignant, Oliguria, Alopecia, Platelet Count Decreased, Renal Tubular Necrosis, Metastases To Kidney, Blood Pressure Decreased, Nephropathy, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Loxoprofen Sodium
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-03

Zometa
    Dosage: 4 mg, with 100 ml of saline
    Indication: Multiple Myeloma
    Start date: 2008-07-01
    End date: 2008-07-01

Maxipime
    Dosage: 1 mg, bid 1 mg with 100 ml of saline, twice daily
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-04

Other drugs received by patient: Dexamethasone; Bortezomib



Possible Maxipime side effects in male

Reported by a pharmacist from Japan on 2012-08-10

Patient: male, weighing 54.0 kg (118.8 pounds)

Reactions: Pyrexia, Hypokalaemia, Haematocrit Decreased, Malaise, RED Blood Cell Count Decreased, DRY Mouth, Hypocalcaemia, Blood Creatinine Increased, Renal Failure Acute, Decreased Appetite, Biopsy Kidney Abnormal, Urine Output Decreased, Urinary Casts Present, Haemoglobin Decreased, Renal Impairment, Renal Failure, Neoplasm Malignant, Alopecia, Oliguria, Platelet Count Decreased, Renal Tubular Necrosis, Blood Pressure Decreased, Nephropathy, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Maxipime
    Dosage: 1 mg, bid 1 mg with 100 ml of saline, twice daily
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-04

Zometa
    Dosage: 4 mg, with 100 ml of saline
    Indication: Multiple Myeloma
    Start date: 2008-07-01
    End date: 2008-07-01

Loxoprofen Sodium
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-03

Other drugs received by patient: Bortezomib; Dexamethasone



Possible Maxipime side effects in 25 year old male

Reported by a consumer/non-health professional from Japan on 2012-04-23

Patient: 25 year old male, weighing 57.0 kg (125.4 pounds)

Reactions: Eyelid Oedema, Pneumonia Viral, Gastrointestinal Haemorrhage, Hepatic Function Abnormal, Graft Versus Host Disease, Disseminated Intravascular Coagulation, Headache, Pyrexia, Oral Herpes, Pneumonia Cytomegaloviral, Generalised Oedema, Pericardial Effusion, Pneumocystis Jiroveci Pneumonia, Interstitial Lung Disease, Liver Function Test Abnormal, Pleural Effusion, Enterocolitis, Bronchopulmonary Aspergillosis, White Blood Cell Count Decreased, Anaemia, Pulmonary Haemorrhage, Renal Impairment, Platelet Count Decreased, Neutrophil Count Decreased

Adverse event resulted in: death, life threatening event, hospitalization

Drug(s) suspected as cause:
Itraconazole
    Dosage: capsule;400-200mg/day(06jul-16jul09)inj.
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-06-06
    End date: 2009-07-16

Foscavir
    Dosage: form:inj1 df= 10 unit nos
    Start date: 2009-07-10
    End date: 2009-07-16

Bactrim
    Dosage: 1df=1tab;800mg/day(02jul-18jul09)inj.
    Administration route: Oral
    Indication: Antibiotic Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-16

Farom
    Administration route: Oral
    Start date: 2009-04-28
    End date: 2009-05-01

Neoral
    Dosage: 09jul-16jul09. 125mg/day sandimmun:inj:50mg/dy:09jul-16jul09
    Administration route: Oral
    Indication: Prophylaxis
    Start date: 2009-04-14
    End date: 2009-07-08

Sprycel
    Administration route: Oral
    Indication: Acute Lymphocytic Leukaemia
    Start date: 2009-04-16
    End date: 2009-07-08

Maxipime
    Start date: 2009-04-24
    End date: 2009-04-27

Other drugs received by patient: Ceftazidime; Solu-Medrol; Ambisome; Piperacillin and Tazobactam; Pentamidine Isethionate; Ganciclovir; Meropenem; Omegacin; Sandimmune; Prednisolone



Possible Maxipime side effects in male

Reported by a physician from Japan on 2012-03-07

Patient: male, weighing 52.0 kg (114.4 pounds)

Reactions: Pyrexia, Hypokalaemia, Malaise, Haematocrit Decreased, RED Blood Cell Count Decreased, DRY Mouth, Hypocalcaemia, Blood Creatinine Increased, Decreased Appetite, Renal Failure Acute, Biopsy Kidney Abnormal, Urine Output Decreased, Urinary Casts Present, Haemoglobin Decreased, Renal Impairment, Renal Failure, Neoplasm Malignant, Oliguria, Alopecia, Platelet Count Decreased, Renal Tubular Necrosis, Blood Pressure Decreased, Nephropathy, Infection

Adverse event resulted in: hospitalization, disablity

Drug(s) suspected as cause:
Zometa
    Dosage: 4 mg, with 100 ml of saline
    Indication: Multiple Myeloma
    Start date: 2008-07-01
    End date: 2008-07-01

Maxipime
    Dosage: 1 mg, bid 1 mg with 100 ml of saline, twice daily
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-04

Loxoprofen Sodium
    Dosage: 60 mg, unk
    Administration route: Oral
    Indication: Pyrexia
    Start date: 2008-07-02
    End date: 2008-07-03

Other drugs received by patient: Bortezomib; Dexamethasone

-- advertisement -- The American Red Cross
 
Home | About Us | Contact Us | Site usage policy | Privacy policy

All Rights reserved - Copyright DrugLib.com, 2006-2017